Home > 106th Congressional Bills > H.R. 4281 (rh) To establish, wherever feasible, guidelines, recommendations, and [Reported in House] ...

H.R. 4281 (rh) To establish, wherever feasible, guidelines, recommendations, and [Reported in House] ...

Web GovRecords.org

  2d Session
                                H. R. 4281



            October 18 (legislative day, September 22), 2000



                                 AN ACT

   To establish, wherever feasible, guidelines, recommendations, and 
 regulations that promote the regulatory acceptance of new or revised 
scientifically valid toxicological tests that protect human and animal 
   health and the environment while reducing, refining, or replacing 
   animal tests and ensuring human safety and product effectiveness.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,


    This Act may be cited as the ``ICCVAM Authorization Act of 2000''.


    In this Act:
            (1) Alternative test method.--The term ``alternative test 
        method'' means a test method that--
                    (A) includes any new or revised test method; and
                    (B)(i) reduces the number of animals required;
                    (ii) refines procedures to lessen or eliminate pain 
                or distress to animals, or enhances animal well-being; 
                    (iii) replaces animals with non-animal systems or 1 
                animal species with a phylogenetically lower animal 
                species, such as replacing a mammal with an 
            (2) ICCVAM test recommendation.--The term ``ICCVAM test 
        recommendation'' means a summary report prepared by the ICCVAM 
        characterizing the results of a scientific expert peer review 
        of a test method.


    (a) In General.--With respect to the interagency coordinating 
committee that is known as the Interagency Coordinating Committee on 
the Validation of Alternative Methods (referred to in this Act as 
``ICCVAM'') and that was established by the Director of the National 
Institute of Environmental Health Sciences for purposes of section 
463A(b) of the Public Health Service Act, the Director of the Institute 
shall designate such committee as a permanent interagency coordinating 
committee of the Institute under the National Toxicology Program 
Interagency Center for the Evaluation of Alternative Toxicological 
Methods. This Act may not be construed as affecting the authorities of 
such Director regarding ICCVAM that were in effect on the day before 
the date of the enactment of this Act, except to the extent 
inconsistent with this Act.
    (b) Purposes.--The purposes of the ICCVAM shall be to--
            (1) increase the efficiency and effectiveness of Federal 
        agency test method review;
            (2) eliminate unnecessary duplicative efforts and share 
        experiences between Federal regulatory agencies;
            (3) optimize utilization of scientific expertise outside 
        the Federal Government;
            (4) ensure that new and revised test methods are validated 
        to meet the needs of Federal agencies; and
            (5) reduce, refine, or replace the use of animals in 
        testing, where feasible.
    (c) Composition.--The ICCVAM shall be composed of the heads of the 
following Federal agencies (or their designees):
            (1) Agency for Toxic Substances and Disease Registry.
            (2) Consumer Product Safety Commission.
            (3) Department of Agriculture.
            (4) Department of Defense.
            (5) Department of Energy.
            (6) Department of the Interior.
            (7) Department of Transportation.
            (8) Environmental Protection Agency.
            (9) Food and Drug Administration.
            (10) National Institute for Occupational Safety and Health.
            (11) National Institutes of Health.
            (12) National Cancer Institute.
            (13) National Institute of Environmental Health Sciences.
            (14) National Library of Medicine.
            (15) Occupational Safety and Health Administration.
            (16) Any other agency that develops, or employs tests or 
        test data using animals, or regulates on the basis of the use 
        of animals in toxicity testing.
    (d) Scientific Advisory Committee.--
            (1) Establishment.--The Director of the National Institute 
        of Environmental Health Sciences shall establish a Scientific 
        Advisory Committee (referred to in this Act as the ``SAC'') to 
        advise ICCVAM and the National Toxicology Program Interagency 
        Center for the Evaluation of Alternative Toxicological Methods 
        regarding ICCVAM activities. The activities of the SAC shall be 
        subject to provisions of the Federal Advisory Committee Act.
            (2) Membership.--
                    (A) In general.--The SAC shall be composed of the 
                following voting members:
                            (i) At least 1 knowledgeable representative 
                        having a history of expertise, development, or 
                        evaluation of new or revised or alternative 
                        test methods from each of--
                                    (I) the personal care, 
                                pharmaceutical, industrial chemicals, 
                                or agriculture industry;
                                    (II) any other industry that is 
                                regulated by the Federal agencies 
                                specified in subsection (c); and
                                    (III) a national animal protection 
                                organization established under section 
                                501(c)(3) of the Internal Revenue Code 
                                of 1986.
                            (ii) Representatives (selected by the 
                        Director of the National Institute of 
                        Environmental Health Sciences) from an academic 
                        institution, a State government agency, an 
                        international regulatory body, or any 
                        corporation developing or marketing new or 
                        revised or alternative test methodologies, 
                        including contract laboratories.
                    (B) Nonvoting ex officio members.--The membership 
                of the SAC shall, in addition to voting members under 
                subparagraph (A), include as nonvoting ex officio 
                members the agency heads specified in subsection (c) 
                (or their designees).
    (e) Duties.--The ICCVAM shall, consistent with the purposes 
described in subsection (b), carry out the following functions:
            (1) Review and evaluate new or revised or alternative test 
        methods, including batteries of tests and test screens, that 
        may be acceptable for specific regulatory uses, including the 
        coordination of technical reviews of proposed new or revised or 
        alternative test methods of interagency interest.
            (2) Facilitate appropriate interagency and international 
        harmonization of acute or chronic toxicological test protocols 
        that encourage the reduction, refinement, or replacement of 
        animal test methods.
            (3) Facilitate and provide guidance on the development of 
        validation criteria, validation studies and processes for new 
        or revised or alternative test methods and help facilitate the 
        acceptance of such scientifically valid test methods and 
        awareness of accepted test methods by Federal agencies and 
        other stakeholders.
            (4) Submit ICCVAM test recommendations for the test method 
        reviewed by the ICCVAM, through expeditious transmittal by the 
        Secretary of Health and Human Services (or the designee of the 
        Secretary), to each appropriate Federal agency, along with the 
        identification of specific agency guidelines, recommendations, 
        or regulations for a test method, including batteries of tests 
        and test screens, for chemicals or class of chemicals within a 
        regulatory framework that may be appropriate for scientific 
        improvement, while seeking to reduce, refine, or replace animal 
        test methods.
            (5) Consider for review and evaluation, petitions received 
        from the public that--
                    (A) identify a specific regulation, recommendation, 
                or guideline regarding a regulatory mandate; and
                    (B) recommend new or revised or alternative test 
                methods and provide valid scientific evidence of the 
                potential of the test method.
            (6) Make available to the public final ICCVAM test 
        recommendations to appropriate Federal agencies and the 
        responses from the agencies regarding such recommendations.
            (7) Prepare reports to be made available to the public on 
        its progress under this Act. The first report shall be 
        completed not later than 12 months after the date of the 
        enactment of this Act, and subsequent reports shall be 
        completed biennially thereafter.


    (a) Identification of Tests.--With respect to each Federal agency 
carrying out a program that requires or recommends acute or chronic 
toxicological testing, such agency shall, not later than 180 days after 
receiving an ICCVAM test recommendation, identify and forward to the 
ICCVAM any relevant test method specified in a regulation or industry-
wide guideline which specifically, or in practice requires, recommends, 
or encourages the use of an animal acute or chronic toxicological test 
method for which the ICCVAM test recommendation may be added or 
    (b) Alternatives.--Each Federal agency carrying out a program 
described in subsection (a) shall promote and encourage the development 
and use of alternatives to animal test methods (including batteries of 
tests and test screens), where appropriate, for the purpose of 
complying with Federal statutes, regulations, guidelines, or 
recommendations (in each instance, and for each chemical class) if such 
test methods are found to be effective for generating data, in an 
amount and of a scientific value that is at least equivalent to the 
data generated from existing tests, for hazard identification, dose-
response assessment, or risk assessment purposes.
    (c) Test Method Validation.--Each Federal agency carrying out a 
program described in subsection (a) shall ensure that any new or 
revised acute or chronic toxicity test method, including animal test 
methods and alternatives, is determined to be valid for its proposed 
use prior to requiring, recommending, or encouraging the application of 
such test method.
    (d) Review.--Not later than 180 days after receipt of an ICCVAM 
test recommendation, a Federal agency carrying out a program described 
in subsection (a) shall review such recommendation and notify the 
ICCVAM in writing of its findings.
    (e) Recommendation Adoption.--Each Federal agency carrying out a 
program described in subsection (a), or its specific regulatory unit or 
units, shall adopt the ICCVAM test recommendation unless such Federal 
agency determines that--
            (1) the ICCVAM test recommendation is not adequate in terms 
        of biological relevance for the regulatory goal authorized by 
        that agency, or mandated by Congress;
            (2) the ICCVAM test recommendation does not generate data, 
        in an amount and of a scientific value that is at least 
        equivalent to the data generated prior to such recommendation, 
        for the appropriate hazard identification, dose-response 
        assessment, or risk assessment purposes as the current test 
        method recommended or required by that agency;
            (3) the agency does not employ, recommend, or require 
        testing for that class of chemical or for the recommended test 
        endpoint; or
            (4) the ICCVAM test recommendation is unacceptable for 
        satisfactorily fulfilling the test needs for that particular 
        agency and its respective congressional mandate.


    (a) Application.--This Act shall not apply to research, including 
research performed using biotechnology techniques, or research related 
to the causes, diagnosis, treatment, control, or prevention of physical 
or mental diseases or impairments of humans or animals.
    (b) Use of Test Methods.--Nothing in this Act shall prevent a 
Federal agency from retaining final authority for incorporating the 
test methods recommended by the ICCVAM in the manner determined to be 
appropriate by such Federal agency or regulatory body.
    (c) Limitation.--Nothing in this Act shall be construed to require 
a manufacturer that is currently not required to perform animal testing 
to perform such tests. Nothing in this Act shall be construed to 
require a manufacturer to perform redundant endpoint specific testing.
    (d) Submission of Tests and Data.--Nothing in this Act precludes a 
party from submitting a test method or scientific data directly to a 
Federal agency for use in a regulatory program.

            Passed the House of Representatives October 17, 2000.


                                                 JEFF TRANDAHL,


Pages: 1

Other Popular 106th Congressional Bills Documents:

1 S. 1940 (is) To amend the Immigration and Nationality Act to reaffirm the United States historic commitment to protecting refugees who are fleeing persecution or torture. [Introduced in Senate] ...
2 H.Con.Res. 375 (eh) [Engrossed in House] ...
3 S.Con.Res. 156 (es) [Engrossed in Senate] ...
4 H.R. 2688 (ih) To reduce traffic congestion, promote economic development, and improve the quality of life in the metropolitan Washington region. [Introduced in House] ...
5 H.R. 3432 (ih) To direct the Minerals Management Service to grant the State of [Introduced in House] ...
6 S. 3184 (is) To amend the Federal Food, Drug, and Cosmetic Act to require premarket consultation and approval with respect to genetically engineered foods, and for other purposes. [Introduced in Senate] ...
7 H.Res. 30 (eh) [Engrossed in House] ...
8 S.Res. 251 (rs) Designating March 25, 2000, as ``Greek Independence Day: A National Day of Celebration of Greek and American Democracy''. [Reported in Senate] ...
9 H.R. 5503 (ih) To direct the Secretary of Veterans Affairs to establish a national cemetery for veterans in the Staten Island, New York, metropolitan area. [Introduced in House] ...
10 H.Res. 372 (ih) Providing for consideration of the bill (H.R. 1495) to amend title XVIII of the Social Security Act to provide for coverage of outpatient prescription drugs under the Medicare Program. [Introduced in House] ...
11 H.R. 2780 (ih) To authorize the Attorney General to provide grants for organizations to find missing adults. [Introduced in House] ...
12 H.R. 1294 (ih) To amend the Internal Revenue Code of 1986 to extend the period for filing for a credit or refund of individual income taxes from 3 to 7 years. [Introduced in House] ...
13 H.R. 4082 (ih) To amend the Federal Deposit Insurance Act and the Federal Home Loan [Introduced in House] ...
14 H.R. 1832 (enr) To reform unfair and anticompetitive practices in the professional boxing industry. [Enrolled bill] ...
15 S. 1611 (is) To amend the Internet Tax Freedom Act to broaden its scope and make the moratorium permanent, and for other purposes. [Introduced in Senate] ...
16 S.Res. 128 (is) Designating March 2000, as ``Arts Education Month''. [Introduced in Senate] ...
17 H.R. 4656 (enr) To authorize the Forest Service to convey certain lands in the Lake Tahoe Basin to the Washoe County School District for use as an elementary school site. [Enrolled bill] ...
18 S. 3142 (is) To expand the boundary of the George Washington Birthplace National Monument, and for other purposes. [Introduced in Senate] ...
19 S. 2511 (is) To establish the Kenai Mountains-Turnagain Arm National Heritage Area in the State of Alaska, and for other purposes. [Introduced in Senate] ...
20 S.J.Res. 43 (rfh) Expressing the sense of Congress that the President of the United States should encourage free and fair elections and respect for democracy in Peru. [Referred in House] ...
21 H.Res. 651 (rh) Providing for consideration of motions to suspend the rules. [Reported in House] ...
22 H.R. 5018 (ih) To amend title 18, United States Code, to modify certain provisions of law relating to the interception of communications, and for other purposes. [Introduced in House] ...
23 H.R. 5012 (ih) To amend the Internal Revenue Code of 1986 to provide an enhanced research credit for the development of smart gun technologies. [Introduced in House] ...
24 H.R. 4425 (pcs) Making appropriations for military construction, family housing, and base realignment and closure for the Department of Defense for the fiscal year ending September 30, 2001, and for other purposes. [Placed on Calendar Senate] %%Filename:...
25 S. 3281 (is) To designate the United States Post Office located at 60 Third Avenue in Long Branch, New Jersey, as the ``Pat King Post Office Building''. [Introduced in Senate] ...
26 H.R. 4292 (rh) To protect infants who are born alive. [Reported in House] ...
27 H.R. 114 (ih) To amend the Federal Deposit Insurance Act and the Federal Credit Union Act to prohibit fees for using teller windows at depository institutions, and for other purposes. [Introduced in House] ...
28 H.R. 775 (ih) To establish certain procedures for civil actions brought for damages relating to the failure of any device or system to process or otherwise deal with the transition from the year 1999 to the year 2000, and for other purposes. [Introduced i...
29 S. 1919 (is) To permit travel to or from Cuba by United States citizens and lawful resident aliens in the United States. [Introduced in Senate] ...
30 H.R. 1340 (ih) To require brokers, dealers, investment companies, and investment advisers to protect the confidentiality of financial information obtained concerning their customers, and for other purposes. [Introduced in House] ...

Other Documents:

106th Congressional Bills Records and Documents

GovRecords.org presents information on various agencies of the United States Government. Even though all information is believed to be credible and accurate, no guarantees are made on the complete accuracy of our government records archive. Care should be taken to verify the information presented by responsible parties. Please see our reference page for congressional, presidential, and judicial branch contact information. GovRecords.org values visitor privacy. Please see the privacy page for more information.
House Rules:

104th House Rules
105th House Rules
106th House Rules

Congressional Bills:

104th Congressional Bills
105th Congressional Bills
106th Congressional Bills
107th Congressional Bills
108th Congressional Bills

Supreme Court Decisions

Supreme Court Decisions


1995 Privacy Act Documents
1997 Privacy Act Documents
1994 Unified Agenda
2004 Unified Agenda

Congressional Documents:

104th Congressional Documents
105th Congressional Documents
106th Congressional Documents
107th Congressional Documents
108th Congressional Documents

Congressional Directory:

105th Congressional Directory
106th Congressional Directory
107th Congressional Directory
108th Congressional Directory

Public Laws:

104th Congressional Public Laws
105th Congressional Public Laws
106th Congressional Public Laws
107th Congressional Public Laws
108th Congressional Public Laws

Presidential Records

1994 Presidential Documents
1995 Presidential Documents
1996 Presidential Documents
1997 Presidential Documents
1998 Presidential Documents
1999 Presidential Documents
2000 Presidential Documents
2001 Presidential Documents
2002 Presidential Documents
2003 Presidential Documents
2004 Presidential Documents

Home Executive Judicial Legislative Additional Reference About Privacy